Chung Shan Medical University Hospital
Taichung, Taiwan
University hospital in Taichung
No. 110號, Section 1, Jianguo N Rd, South District, Taichung City, 402
About Chung Shan Medical University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chung Shan Medical University
22
Pfizer
20
Janssen Research & Development, LLC
9
Eli Lilly and Company
8
Daiichi Sankyo, Inc.
6
Amgen
5
Boehringer Ingelheim
4
Takeda
4
Galapagos NV
3
BeiGene
2
Chugai Pharma Taiwan
2
Clinical Trials at Chung Shan Medical University Hospital
During the past decade, Chung Shan Medical University Hospital conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 27 clinical trials were completed, i.e. on
average, 30.7% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 12 clinical trials were completed. i.e. 29.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
2007-05-01
2010-03-01
Completed
865
The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome
2008-04-01
2009-12-01
Unknown status
220
Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis
2008-03-01
2009-07-01
Completed
60
A Post-Marketing Surveillance Study On Erbitux® (Cetuximab) In Patients With Metastatic Colorectal Cancer Refractory To Irinotecan Containing Treatment
2008-01-01
2010-11-01
Completed
286
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B
2009-06-01
Completed
1,640
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chung Shan Medical University Hospital" #1 sponsor was "Chung Shan Medical University" with 22 trials, followed by "Pfizer" with 20 trials
sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored, "Eli Lilly and Company" with 8 trials sponsored and "Daiichi Sankyo, Inc."
with 8 trials sponsored. Other sponsors include 56 different institutions and
companies that sponsored additional 44 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chung Shan Medical University Hospital"
#1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Dermira, Inc." with 3 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 29 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Chung Shan Medical University Hospital
According to Clinical.Site data, the most researched conditions in "Chung Shan Medical University Hospital" are
"Carcinoma, Non-Small-Cell Lung" (8 trials), "Atopic Dermatitis" (6 trials), "Ankylosing Spondylitis" (5 trials), "Non-small Cell Lung Cancer" (4 trials) and "Rheumatoid Arthritis" (4 trials). Many other conditions were trialed in "Chung Shan Medical University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Chung Shan Medical University Hospital
Most popular intervention types in "Chung Shan Medical University Hospital" are "Drug" (92 trials), "Other" (22 trials), "Biological" (10 trials), "Device" (6 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (39 trials), "Carboplatin" (7 trials), "Pemetrexed" (6 trials), "Amivantamab" (5 trials) and "Lazertinib" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Chung Shan Medical University Hospital
The vast majority of trials in "Chung Shan Medical University Hospital" are
122 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Chung Shan Medical University Hospital
Currently, there are NaN active trials in "Chung Shan Medical University Hospital".
undefined are not yet recruiting,
25 are recruiting,
20 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 60 completed trials in Chung Shan Medical University Hospital,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Chung Shan Medical University Hospital, 6 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 58 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 14 trials that are defined as “Not Applicable".